IP Library Granted Patent US 8,357,130
Granted Patent B2
US 8,357,130 · App. 12/033,558 · Granted Jan 22, 2013

Wound care apparatus

Inventors: Joshua David Smith (Nashville, TN); David Myron Smith (Burns, TN)
Assignees: Joshua David Smith; David Myron Smith
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,357,130
App. No.
12/033,558
Granted
Jan 22, 2013
Kind
B2
Abstract

Disclosed is an apparatus for the treatment of a wound on a patient. The apparatus is capable of administering localized negative pressure therapy to the wound using a hospital wall vacuum source and a drain line for removing exudate from the wound. The apparatus may also be capable of administering localized hyperbaric oxygen therapy to the wound using a hospital wall oxygen source and a supply line for supplying oxygen to the wound. The apparatus includes at least one regulator to control the application of negative pressure therapy and hyperbaric oxygen therapy.

Claims (18)

1. A method for treating a wound comprising:

connecting the supply line to a pressure regulator connected to a hospital wall oxygen line associated with a hospital line oxygen source

regulating the pressure applied to the wound via the drain line such that the pressure applied to the wound is greater than the hospital line negative pressure;

regulating the pressure applied to the wound via the supply line such that the pressure applied to the wound is less than the hospital wall oxygen line pressure;

administering hyperbaric fluid therapy to the wound via the supply line for approximately 10 seconds to approximately 60 seconds; and

administering negative pressure therapy to the wound via the drain line at less than 1 atmosphere for approximately 20 seconds to approximately 180 seconds;

wherein the hyperbaric oxygen therapy and the negative pressure therapy are administered intermittently such that negative pressure therapy is administered immediately following the administration of hyperbaric oxygen therapy and hyperbaric oxygen therapy is administered immediately following the administration of negative pressure therapy.

2. The method of claim 1 , wherein the supply line draws in a steady supply of fluid from a reservoir to the system and is passively activated by the application of negative pressure wound therapy.

3. The method of claim 1 , wherein the wound is subject to an absolute pressure of from approximately 60 mmHg to approximately 160 mmHg during the administration of negative pressure therapy.

4. The method of claim 1 , wherein administering hyperbaric oxygen therapy comprises supplying oxygen to the wound wherein the oxygen comprises at least one of: oxygen or humidified oxygen.

5. The method of claim 4 , wherein the oxygen or humidified oxygen is administered at approximately 0.1 liters per minute to approximately 3 liters per minute.

6. The method of claim 1 , wherein administering hyperbaric oxygen therapy comprises supplying oxygen to the wound, wherein the oxygen comprises at least one non-oxygen drug.

7. The method of claim 6 , wherein the non-oxygen drug is supplied in powder form via gas.

8. The method of claim 7 , wherein the non-oxygen drug is supplied in vapor form via humidified gas.

9. The method of claim 8 , wherein the non-oxygen drug is supplied via a humidification device operatively connected to the supply line.

10. The method of claim 1 , further comprising receiving information from a diffusion sensor relating to the diffusion into the wound of oxygen supplied at least during hyperbaric oxygen therapy.

11. The method of claim 10 , further comprising increasing the oxygen flow rate or the pressure at the wound during hyperbaric oxygen therapy in response to information received from the diffusion sensor indicating that the oxygen diffusion rate is below a desired level.

12. The method of claim 10 , further comprising increasing the duration of the administration of hyperbaric oxygen therapy relative to the negative pressure therapy in response to information received from the diffusion sensor indicating that the oxygen diffusion rate is below a desired level.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 26, 2019
From: MCLEMORE, JOHN C.
To: PHASE ONE HEALTH, LLC
Reel/Frame 048696/0731 →
COURT APPOINTMENT Recorded Mar 26, 2019
From: INTEGRATED HEALING TECHNOLOGIES, LLC
To: MCLEMORE, JOHN C.
Reel/Frame 048697/0451 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 30, 2016
From: SMITH, JOSHUA DAVID; SMITH, DAVID MYRON
To: PIONEER TECHNOLOGY, LLC
Reel/Frame 039589/0213 →
CHANGE OF NAME Recorded Aug 30, 2016
From: PIONEER TECHNOLOGY, LLC
To: INTEGRATED HEALING TECHNOLOGIES, LLC
Reel/Frame 039884/0062 →
Continuity (3)
Continuation In Part 11602653 · Nov 21, 2006
Provisional Application 60890275 · Feb 16, 2007
Related Publication 20080140029A1 · Jun 12, 2008